BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9439385)

  • 21. Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media.
    DeMaria TF; Murwin DM
    Laryngoscope; 1997 Mar; 107(3):369-72. PubMed ID: 9121315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
    Kariya S; Okano M; Aoji K; Kosaka M; Chikumoto E; Hattori H; Yuen K; Nishioka S; Nishioka K; Nishizaki K
    Clin Diagn Lab Immunol; 2003 May; 10(3):417-22. PubMed ID: 12738641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cytokine levels in bilateral ear effusions in patients with otitis media secretoria.
    Matkovic S; Vojvodic D; Baljosevic I
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):450-3. PubMed ID: 17765774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion.
    Zielnik-Jurkiewicz B; Stankiewicz-Szymczak W
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1369-78. PubMed ID: 26078091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic characteristics of cytokines in otitis media with effusion.
    Himi T; Suzuki T; Kodama H; Takezawa H; Kataura A
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():21-5. PubMed ID: 1416648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of accidental trauma on cytokine and endotoxin production.
    Hoch RC; Rodriguez R; Manning T; Bishop M; Mead P; Shoemaker WC; Abraham E
    Crit Care Med; 1993 Jun; 21(6):839-45. PubMed ID: 8504650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxin in middle ear effusions tested with Limulus assay.
    Iino Y; Kaneko Y; Takasaka T
    Acta Otolaryngol; 1985; 100(1-2):42-50. PubMed ID: 4040697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxin in middle ear effusions: in cases with persistent effusion after acute otitis media.
    Iino Y; Yuasa R; Kaneko Y; Takasaka T; Kawamoto K
    Auris Nasus Larynx; 1985; 12 Suppl 1():S94-6. PubMed ID: 3835949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of T-helper cell 2 cytokine regulation of chronic otitis media with effusion.
    Smirnova MG; Birchall JP; Pearson JP
    Acta Otolaryngol; 2005 Oct; 125(10):1043-50. PubMed ID: 16298784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression and correlation of Hsp 70 and Hsp 27 in serous middle ear effusion fluids of pediatric patients-a preliminary study.
    Min HJ; Choe JW; Chang MY; Kim KS; Lee SY; Mun SK
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():145-149. PubMed ID: 28964286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compositional differences between bilateral middle ear effusions in otitis media with effusion: evidence for a different etiology?
    Johnson IJ; Brooks T; Hutton DA; Birchall JP; Pearson JP
    Laryngoscope; 1997 May; 107(5):684-9. PubMed ID: 9149175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RANTES in otitis media with effusion: presence, role and correlation with cytokines and microbiology.
    Schousboe LP; Rasmussen LM; Ovesen T
    APMIS; 2001 Jun; 109(6):441-6. PubMed ID: 11506476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions.
    Yellon RF; Doyle WJ; Whiteside TL; Diven WF; March AR; Fireman P
    Arch Otolaryngol Head Neck Surg; 1995 Aug; 121(8):865-9. PubMed ID: 7619411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions.
    Ball SS; Prazma J; Dais CG; Triana RJ; Pillsbury HC
    Ann Otol Rhinol Laryngol; 1997 Aug; 106(8):633-9. PubMed ID: 9270424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of interleukin 6 in middle ear effusions.
    Yellon RF; Leonard G; Marucha P; Sidman J; Carpenter R; Burleson J; Carlson J; Kreutzer D
    Arch Otolaryngol Head Neck Surg; 1992 Jul; 118(7):745-8. PubMed ID: 1627297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection.
    Hebda PA; Piltcher OB; Swarts JD; Alper CM; Zeevi A; Doyle WJ
    Laryngoscope; 2002 Sep; 112(9):1657-62. PubMed ID: 12352682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of vascular endothelial growth factor in pediatric otitis media with effusion.
    Sekiyama K; Ohori J; Matsune S; Kurono Y
    Auris Nasus Larynx; 2011 Jun; 38(3):319-24. PubMed ID: 21227609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytokine expression in effusions of secretory otitis media].
    Gao W; Liu S; Hao H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 15(4):157-8. PubMed ID: 12541637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of gastric pepsin in the inflammatory cascade of pediatric otitis media.
    O'Reilly RC; Soundar S; Tonb D; Bolling L; Yoo E; Nadal T; Grindle C; Field E; He Z
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):350-7. PubMed ID: 25633964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between presence of viable bacteria and presence of endotoxin in middle-ear effusions.
    Dingman JR; Rayner MG; Mishra S; Zhang Y; Ehrlich MD; Post JC; Ehrlich GD
    J Clin Microbiol; 1998 Nov; 36(11):3417-9. PubMed ID: 9774611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.